tradingkey.logo

Prestige Consumer Healthcare Inc

PBH
61.400USD
+0.940+1.55%
取引時間 ET15分遅れの株価
2.95B時価総額
14.70直近12ヶ月PER

Prestige Consumer Healthcare Inc

61.400
+0.940+1.55%

詳細情報 Prestige Consumer Healthcare Inc 企業名

Prestige Consumer Healthcare Inc. is consumer healthcare products company. The Company is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. It operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.

Prestige Consumer Healthcare Incの企業情報

企業コードPBH
会社名Prestige Consumer Healthcare Inc
上場日Feb 10, 2005
最高経営責任者「CEO」Mr. Ronald M. (Ron) Lombardi, CPA
従業員数600
証券種類Ordinary Share
決算期末Feb 10
本社所在地660 White Plains Rd.
都市TARRYTOWN
証券取引所NYSE Consolidated
United States of America
郵便番号10591
電話番号19145246800
ウェブサイトhttps://www.prestigebrands.com/
企業コードPBH
上場日Feb 10, 2005
最高経営責任者「CEO」Mr. Ronald M. (Ron) Lombardi, CPA

Prestige Consumer Healthcare Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%
Mr. Adel Mekhail
Mr. Adel Mekhail
Executive Vice President - Marketing & Sales
Executive Vice President - Marketing & Sales
15.16K
-30.95%
Ms. Dawn M. Zier
Ms. Dawn M. Zier
Independent Director
Independent Director
14.33K
+17.11%
Dr. Celeste A. Clark, Ph.D.
Dr. Celeste A. Clark, Ph.D.
Independent Director
Independent Director
11.33K
+22.68%
Mr. James C. D'arecca
Mr. James C. D'arecca
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Ronald M. (Ron) Lombardi, CPA
Mr. Ronald M. (Ron) Lombardi, CPA
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
355.35K
-10.40%
Ms. Christine (Chris) Sacco, CPA
Ms. Christine (Chris) Sacco, CPA
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
63.23K
-32.80%
Mr. John E. Byom
Mr. John E. Byom
Lead Independent Director
Lead Independent Director
52.39K
+4.16%
Mr. William C. P'Pool, J.D.
Mr. William C. P'Pool, J.D.
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
35.30K
+10.28%
Mr. Jeffrey Zerillo
Mr. Jeffrey Zerillo
Senior Vice President - Operations
Senior Vice President - Operations
35.20K
+6.66%
Ms. Sheila A. Hopkins
Ms. Sheila A. Hopkins
Independent Director
Independent Director
27.92K
+8.11%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
データなし
地域別USD
会社名
収益
比率
United States
897.54M
78.89%
Rest of world
240.22M
21.11%
事業別
地域別
データなし

株主

更新時刻: Fri, Oct 17
更新時刻: Fri, Oct 17
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
他の
60.10%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
14.62%
The Vanguard Group, Inc.
11.40%
Dimensional Fund Advisors, L.P.
5.14%
Ariel Investments, LLC
4.58%
State Street Investment Management (US)
4.16%
他の
60.10%
種類
株主統計
比率
Investment Advisor
66.27%
Investment Advisor/Hedge Fund
30.99%
Research Firm
3.47%
Hedge Fund
1.89%
Pension Fund
1.33%
Individual Investor
1.29%
Sovereign Wealth Fund
1.12%
Family Office
0.61%
Bank and Trust
0.53%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
667
52.11M
108.37%
-2.03M
2025Q2
667
53.74M
109.15%
-2.00M
2025Q1
670
54.01M
109.68%
-1.79M
2024Q4
653
54.79M
110.61%
+365.71K
2024Q3
633
53.04M
107.02%
-1.71M
2024Q2
622
53.11M
106.92%
-2.21M
2024Q1
614
53.06M
106.87%
-2.26M
2023Q4
602
52.89M
106.58%
-3.51M
2023Q3
590
52.77M
106.53%
-2.81M
2023Q2
589
51.93M
104.86%
-4.95M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
7.03M
14.28%
-239.29K
-3.29%
Jun 30, 2025
The Vanguard Group, Inc.
5.62M
11.42%
-2.89K
-0.05%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
2.47M
5.02%
-244.43K
-9.00%
Jun 30, 2025
Ariel Investments, LLC
2.20M
4.47%
-316.61K
-12.57%
Jun 30, 2025
State Street Investment Management (US)
2.00M
4.06%
+1.65K
+0.08%
Jun 30, 2025
Macquarie Investment Management
1.97M
4%
-285.27K
-12.66%
Jun 30, 2025
Kayne Anderson Rudnick Investment Management, LLC
1.75M
3.55%
+168.12K
+10.64%
Jun 30, 2025
Allspring Global Investments, LLC
1.52M
3.09%
-94.00K
-5.82%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.41M
2.87%
+9.46K
+0.67%
Jun 30, 2025
Goldman Sachs Asset Management, L.P.
949.09K
1.93%
+534.84K
+129.11%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Thu, Nov 6
更新時刻: Thu, Nov 6
銘柄名
比率
Invesco Pharmaceuticals ETF
2.51%
Schwab Ariel Opportunities ETF
2.33%
SPDR S&P Pharmaceuticals ETF
2.31%
Invesco S&P SmallCap Health Care ETF
1.95%
Congress SMid Growth ETF
1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.73%
iShares U.S. Pharmaceuticals ETF
1.13%
Brandes US Small-Mid Cap Value ETF
0.86%
JPMorgan Active Small Cap Value ETF
0.72%
Invesco S&P SmallCap Low Volatility ETF
0.63%
詳細を見る
Invesco Pharmaceuticals ETF
比率2.51%
Schwab Ariel Opportunities ETF
比率2.33%
SPDR S&P Pharmaceuticals ETF
比率2.31%
Invesco S&P SmallCap Health Care ETF
比率1.95%
Congress SMid Growth ETF
比率1.92%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.73%
iShares U.S. Pharmaceuticals ETF
比率1.13%
Brandes US Small-Mid Cap Value ETF
比率0.86%
JPMorgan Active Small Cap Value ETF
比率0.72%
Invesco S&P SmallCap Low Volatility ETF
比率0.63%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI